Showing results (1-10 of 34) with videos related to
Sort By:
Pageof 4
Open Forum Infectious Diseases|November 26, 2020
Opportunities to Offer Harm Reduction to People who Inject Drugs During Infectious Disease Encounters: Narrative ReviewAlyssa M Peckham, Erika H YoungFederal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|February 16, 2019
The Overdose Education and Naloxone Distribution Program at a VA HospitalAlyssa M Peckham, Douglas L BoggsJournal of Pharmacy Practice|February 20, 2018
VMAT2 Inhibitors for Tardive Dyskinesia-Practice ImplicationsAlyssa M Peckham, Jessica A NicewonderAmerican Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 24, 2021
State-level response to gabapentin misuse in the United States: Implications and future directionZoe A Karavolis, Andrew B Su, Alyssa M PeckhamExpert Opinion on Drug Safety|October 7, 2017
Policies to mitigate nonmedical use of prescription medications: how should emerging evidence of gabapentin misuse be addressed?Alyssa M Peckham, Kathleen A Fairman, David A SclarRisk Management and Healthcare Policy|August 30, 2018
Gabapentin use, abuse, and the US opioid epidemic: the case for reclassification as a controlled substance and the need for pharmacovigilanceAlyssa M Peckham, Maria J Ananickal, David A SclarClinical Drug Investigation|April 29, 2017
Prevalence of Gabapentin Abuse: Comparison with Agents with Known Abuse Potential in a Commercially Insured US PopulationAlyssa M Peckham, Kathleen A Fairman, David A SclarCNS Spectrums|October 9, 2018
Drug-drug interactions and clinical considerations with co-administration of antiretrovirals and psychotropic drugsKellie J Goodlet, Monika T Zmarlicka, Alyssa M PeckhamDrug Safety|September 29, 2017
All-Cause and Drug-Related Medical Events Associated with Overuse of Gabapentin and/or Opioid Medications: A Retrospective Cohort Analysis of a Commercially Insured US PopulationAlyssa M Peckham, Kathleen A Fairman, David A SclarJournal of Attention Disorders|February 4, 2017
Diagnosis and Treatment of ADHD in the United States: Update by Gender and RaceKathleen A Fairman, Alyssa M Peckham, David A SclarPageof 4